Ketamine and Psychedelic Therapy in New York City

How to Find Ketamine Care and a Psychedelic Therapist in New York City

Getting ketamine treatment near you in New York City comes down to two paths. You can go to a clinic in Manhattan, Brooklyn, or Queens for an in-person IV or intramuscular infusion, or you can do ketamine therapy at home through telehealth. Mindbloom takes the at-home path. Eligibility begins with an online clinical evaluation by a New York-licensed clinician, and when it is a good fit, a prescription for sublingual ketamine is filled by a licensed pharmacy and shipped to you, with clinician support before and after each session. Ketamine prescription online through a real evaluation, not a quick questionnaire, is what makes this both accessible and safe.

If you are searching for a psychedelic therapist, or for psychedelics near you in New York City, it helps to know what is actually available in New York. Psilocybin and MDMA are not legal for therapy here, so in practice the psychedelic-class therapy you can start now is ketamine. Mindbloom pairs the medicine with the guided preparation and integration people associate with psychedelic therapy, which you can read more about in this psychedelic therapy guide.

New York City is dense, but in-clinic access is not evenly spread. Providers cluster in Manhattan, from the Financial District up through Chelsea and the Upper East Side, and in Brooklyn neighborhoods like Brooklyn Heights and Williamsburg, with additional clinics in Queens. Which borough you live in, and the commute between them, shapes how convenient in-person care really is. At-home care removes the trip entirely, which is a large part of why it fits a city this size. Ketamine therapy is legal statewide, and you can learn more on our ketamine therapy in New York page.

Your Ketamine and Psychedelic Therapy Options in New York City

New Yorkers weigh a few options for ketamine and psychedelic therapy. Here is how they compare on setting, format, and cost as of 2026.

Psilocybin, MDMA, LSD, and ayahuasca all draw interest, but none is legally available for therapy in New York today, and no New York City ordinance changes that.¹¹ That is why ketamine is the psychedelic-class therapy New Yorkers can actually begin now. On the evidence it holds up: Mindbloom's reported depression response of 56.6% is at or above the roughly 37% to 42% reported in the largest controlled trials of single-dose psilocybin for depression, on a far larger published evidence base and delivered at home rather than in a full-day, in-person licensed-center session.¹ ⁸

For in-clinic ketamine, prices in New York City run higher than the national average because of the city's costs, generally about $500 to $900 or more per infusion.¹² A Lower Manhattan clinic lists $525 per infusion, for example, and other IV and IM providers operate across Brooklyn and Queens.¹³ Spravato, the in-clinic esketamine nasal spray, is offered at several New York City psychiatric practices and may be covered by insurance for people who qualify, subject to the insurer's approval.

What Ketamine Therapy Can Help With

Depression is the condition ketamine therapy is used for most, and it is Mindbloom's flagship indication. In its peer-reviewed subcutaneous study, Mindbloom reported a 56.6% depression response rate and 27.7% remission.¹ Ketamine treatment for depression is the core of what Mindbloom does, and depression care is available to eligible adults across New York City by telehealth.

Mindbloom is also the only at-home ketamine provider with peer-reviewed PTSD outcomes, reporting a 76.7% response rate.¹ Its programs also address anxiety, grief, burnout, and sleep. Mindbloom does not claim conditions its evidence does not support, so you will not find promises here for chronic pain, OCD, or addiction.

Mindbloom's Psychedelic Therapy Programs and Outcomes

Mindbloom has delivered more than 800,000 guided at-home sessions and is one of the largest at-home psychedelic-therapy providers. Its outcomes are peer reviewed. A subcutaneous study (Parks 2026) covers depression, anxiety, and PTSD in a single study, and two earlier peer-reviewed studies (Hull 2022 and Mathai 2024) cover its sublingual protocol, with research preprints extending the evidence to grief, burnout, and sleep. That is the largest published evidence base in at-home ketamine therapy, and Mindbloom is the only at-home provider with peer-reviewed PTSD outcomes.

_{¹ Subcutaneous, six-session course (Parks AC et al. J Med Internet Res. 2026). Response = at least 50% reduction (PHQ-9/GAD-7) or at least 10 points (PCL-5); remission = final PHQ-9/GAD-7 under 5, or at least a 10-point reduction with PCL-5 under 33. ² Grief (PGD-13), n=503. ³ Burnout (MBI-GS), n=395. ⁴ Sleep (PHQ-9 Item 3), n=13,963; single-item measure, and ketamine is off-label for sleep. ᵃ Grief remission = no longer met diagnostic criteria (71.1% DSM-5-TR). ᵇ Burnout response = improved on at least one dimension (69.6%); remission = fell below the burnout threshold (59.5%). ᶜ Sleep remission = complete resolution (score 0). Individual results vary.}

Mindbloom offers tailored programs that use the psychedelic modality to work toward specific outcomes, not just a prescription. Programs include Grief, Habit Change, Anxiety, Depression, Self-Love, and Burnout.

How Mindbloom's reported outcomes compare with published studies of other treatments:

• Mindbloom's reported depression response rate is roughly 38% higher than the rate reported in a study of psychotherapy for depression, at 56.6% versus about 41%, and reached faster.¹ ⁵
• Mindbloom's reported at-home PTSD response rate exceeds the rate reported in the leading repeated-infusion IV ketamine trial, at 76.7% versus 67%.¹ ⁶
• Mindbloom's reported grief outcomes are as high as those reported in studies of the gold-standard grief therapy, in about a third of the time, at 76% response, within its 66% to 82% range, reached in about 6 sessions versus 16.² ⁷

For how at-home sublingual compares with in-clinic IV specifically, which is a common question in a city with this many infusion clinics, see Mindbloom's comparison of sublingual and IV ketamine.

Is Psychedelic Therapy Legal in New York?

Ketamine is legal to prescribe in New York and in every other state. It is a Schedule III controlled substance, which means the DEA recognizes an accepted medical use, and clinicians prescribe it off-label for depression, anxiety, and PTSD. At-home sublingual ketamine through telehealth is available to eligible adults in New York City now.

The other psychedelics people ask about are a different story. Psilocybin and MDMA remain Schedule I in New York, with no state decriminalization and no licensed program.¹¹ New York City itself has not decriminalized psilocybin, and no borough district attorney, in Manhattan, Brooklyn, Queens, or the Bronx, has issued a deprioritization policy, so state law applies the same across the whole city.¹¹ MDMA-assisted therapy is not FDA approved and is not an available treatment. For now, ketamine is the psychedelic-class therapy New Yorkers can legally access, and Mindbloom delivers it from home. That direction has federal momentum behind it: in April 2026 a federal executive order directed the FDA and DEA to accelerate research and access for psychedelic therapies, including ketamine, the one already available under medical supervision today.¹⁴

How At-Home Ketamine Therapy Works With Mindbloom

Care starts with an online medical intake and a video evaluation with a New York-licensed clinician, who reviews your history and decides whether ketamine is appropriate for you. If it is, you receive a personalized plan and a Bloombox toolkit, and a required peer treatment monitor is present for every session. You do the sessions at home, guided by the Mindbloom app, and follow them with structured integration, including one-to-one coaching and daily Integration Circles. Treatment frequency is personalized and clinician guided rather than a fixed schedule, and the benefits tend to build cumulatively alongside the more immediate relief many people feel early on.

Safety and Who Ketamine Therapy Is For

Ketamine therapy is a prescription medical treatment for eligible adults, not something available on demand. A licensed clinician confirms eligibility before treatment begins and screens for conditions where ketamine is not appropriate, such as uncontrolled hypertension, psychotic disorders, or substance use disorders. Common side effects include dissociation, increased blood pressure, nausea, and dizziness, and you should not drive until the day after a session. Ketamine is not FDA approved for depression, anxiety, or PTSD, and is prescribed off-label based on a clinician's judgment.

Cost and Insurance for Ketamine Therapy in New York City

At-home ketamine therapy with Mindbloom runs about $165 to $215 per session within a program, and you can see current program pricing on the pricing page. Sessions are HSA and FSA eligible, and Mindbloom provides superbills you can submit for possible out-of-network reimbursement. In-clinic IV ketamine for mental health is generally not covered by insurance in New York and is paid out of pocket, typically running higher per session in New York City than the at-home range.¹² Spravato may be covered by insurance for people who qualify, subject to the insurer's approval.

Working Alongside Your Therapist

Ketamine therapy works best as part of your broader care, not a replacement for it. Mindbloom coordinates with your existing therapist or prescriber where that helps, and its programs are built around preparation and integration so the work continues between sessions. If you are starting without a therapist, the program structure provides that guided support directly.

Ketamine and Psychedelic Therapy Across the Five Boroughs

Because Mindbloom is delivered by telehealth, at-home ketamine therapy reaches eligible adults anywhere in New York City with a New York address. That includes Manhattan, Brooklyn, Queens, the Bronx, and Staten Island, and the neighborhoods within them, from the Financial District, Chelsea, and the Upper East Side to Brooklyn Heights, Williamsburg, and across Queens. Wherever you are in the city, care does not depend on traveling to a clinic in another borough. Eligibility begins with an online clinician evaluation.